C07C 233/31
With the substituted hydrocarbon radical bound to the nitrogen atom of the
Official title: with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
C07C233/31 (With the substituted hydrocarbon radical bound to the nitrogen atom of the) appears on 109 US grants and 108 published applications in this corpus.
Search patents in C07C- Granted patents
- 109
- Published applications
- 108
- Assignees
- 98
- Inventors
- 389
- Latest grant
- 14 Oct 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 2 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 4 | 0 |
| 1998 | 3 | 0 |
| 1999 | 9 | 0 |
| 2000 | 2 | 0 |
| 2001 | 3 | 0 |
| 2002 | 5 | 7 |
| 2003 | 0 | 4 |
| 2004 | 2 | 15 |
| 2005 | 5 | 6 |
| 2006 | 6 | 2 |
| 2007 | 1 | 10 |
| 2008 | 5 | 6 |
| 2009 | 3 | 3 |
| 2010 | 2 | 2 |
| 2011 | 4 | 2 |
| 2012 | 1 | 2 |
| 2013 | 5 | 6 |
| 2014 | 3 | 3 |
| 2015 | 3 | 5 |
| 2016 | 2 | 8 |
| 2017 | 7 | 2 |
| 2018 | 2 | 4 |
| 2019 | 2 | 4 |
| 2020 | 6 | 6 |
| 2021 | 4 | 2 |
| 2022 | 3 | 3 |
| 2023 | 1 | 2 |
| 2024 | 3 | 2 |
| 2025 | 3 | 1 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Sphingolipid, and dermatologic composition comprising same for external application14 Oct 2025US 12,441,678 B2Croda Korea Ltd
- Compositions and methods for treating cancer23 Sep 2025US 12,421,185 B2Cedars-Sinai Medical Center
- Pregabalin artificial hapten, artificial antigen and preparation method therefor and application thereof20 May 2025US 12,304,882 B2Hangzhou Tongzhou Biotechnology Co., Ltd.
- Inhibitors of the n-terminal domain of the androgen receptor10 Dec 2024US 12,162,818 B2The Regents of the University of California
- Phenalene-1-one-containing photosensitizer composition, phenalene-1-one compound and the use thereof21 May 2024US 11,987,557 B2Trioptotec GmbH
- Compositions and methods for treating cancer15 Jan 2026US 2026/0015316 A1Cedars-Sinai Medical Center
- Small molecule antagonists of pf411 Sep 2025US 2025/0281424 A1Fox Chase Chemical Diversity Center, Inc.
- Pregabalin artificial hapten, artificial antigen and preparation method therefor and application thereof30 May 2024US 2024/0174600 A1Hangzhou Tongzhou Biotechnology Co., Ltd.
- Pharmaceutical composition for preventing or treating viral infections containing piperlongumine-based compound as active ingredient28 Mar 2024US 2024/0100031 A1Huscion Co., Ltd.
- Novel sphingolipid, and dermatologic composition comprising same for external application26 Oct 2023US 2023/0339848 A1Solus Biotech Co., Ltd.
Most cited
By later US patents
- 2-amino-1,3-propanediol compound and immunosuppressant76US 5,604,229 ATaito Co., Ltd. · 1997
- Modified lysine-mimetic compounds47US 7,622,496 B2Wyeth · 2009
- Compounds and methods for reversible modification of biologically active molecules47US 8,541,548 B2Arrowhead Madison Inc. · 2013
- Benzene compound and pharmaceutical use thereof40US 5,948,820 AYoshitomi Pharmaceutical Industries, Ltd. · 1999
- Quinones as disease therapies40US 6,809,176 B2SLIL Biomedical Corporation · 2004